| Patents for A61P 11 - Drugs for disorders of the respiratory system (87,767) |
|---|
| 05/10/2005 | US6890929 Immunosuppressants; lupus, multiple sclerosis, skin disorders, antiarthritic agents, antihistamines, antiulcer agents, Crohn's disease |
| 05/10/2005 | US6890928 Aromatic sulfone hydroxamic acids and their use as protease inhibitors |
| 05/10/2005 | US6890922 For treatment of erectile dysfunction as well as female sexual dysfunction, incontinence, and hypertrophy of the prostate; inhibitors of cGMP-metabolizing phosphodiesterases (cGMP= cyclic guanosine monophosphate) |
| 05/10/2005 | US6890920 Therapeutic treatment of asthma, chronic obstructive pulmonary disease, rhinorrhea due to the common cold, rhinitis |
| 05/10/2005 | US6890915 Hydantoins and related heterocycles as inhibitors of matrix metalloproteinases and/or TNF-α converting enzyme (TACE) |
| 05/10/2005 | US6890914 Method of locking 1α-OH of vitamin D compounds in axial orientation |
| 05/10/2005 | US6890907 Method of treating endobronchial infection by administering a nebulized unit dosage of an aqueous solution of tobramycin over given dosage and time, as well as specified aerosol particle sizes |
| 05/10/2005 | US6890534 Aiolos genes and polypeptides of the present invention are useful for studying, diagnosing and/or treating diseases associated with unwanted cell proliferation, e.g., leukemias or lymphomas |
| 05/10/2005 | CA2250569C Novel phenanthridines substituted in the 6 position |
| 05/06/2005 | WO2005039602A1 Pharmacologically functional water and use thereof |
| 05/06/2005 | WO2005039599A1 Matrix metalloprotease inhibitor containing polylactic acid mixture |
| 05/06/2005 | WO2005039589A2 Cftr channel modulators |
| 05/06/2005 | WO2003068746A8 Aryl ureas as kinase inhibitors |
| 05/06/2005 | WO2003010286A3 Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 05/06/2005 | CA2542226A1 Novel diazaspiroalkanes and their use for treatment of ccr8 mediated diseases |
| 05/06/2005 | CA2540765A1 Pyrimidin-2-amine derivatives and their use as a2b adenosine receptor antagonists |
| 05/05/2005 | US20050096468 Inhibitors of histone deacetylase |
| 05/05/2005 | US20050096397 Adding trifluoroacetic acid dropwise to a solution of dimethylphenylsilane and (S)-amino-1-(2,5-dimethoxy-phenyl)-1-propanone, the amino group of which is protected, for example, with a methoxycarbonyl group; reduction; deprotecting; salt formation |
| 05/05/2005 | US20050096388 Compositions and methods for treating or preventing diseases of body passageways |
| 05/05/2005 | US20050096356 2-[[6-Methoxy-3-pyridinyl]methyl]amino-N-[3-(trifluoromethyl)phenyl]benzamide hydrochloride salt or its tautomer; treating retinopathy or age-related macula degeneration |
| 05/05/2005 | US20050096321 affinity for peripheral-type benzodiazepine receptors; in vitro and in vivo affinity; chemical intermediates |
| 05/05/2005 | US20050096316 Quinoline derivatives(2) |
| 05/05/2005 | US20050096313 Substance P; 2-(phenyl)-4-(3-oxo-piperazin-1-yl-)-piperidine-1-carboxylic acid; benzyl-methylamide; antagonists of the NK1 receptor; antidepressant, antiolytic; antiemetic |
| 05/05/2005 | US20050096310 Antagonist of phosphorylation of myosin regulatory light chain, enzyme inhibitors; therapeutic treatment of glaucoma, bronchial asthma, chronic obstructive pulmonary disease, nervous system disorders; 4-(2,3-dihydro-1,5-diazaphenalen-1-yl)cyclohexylamine |
| 05/05/2005 | US20050096271 Fusion of polypeptides and immunoglobulin protein; immunotherapy ; antiallergens; antiarthritic agents; anticancer agents; antiinflammatory agents |
| 05/05/2005 | US20050096268 Treatment of fibrosis by antagonism of IL-13 and IL-13 receptor chains |
| 05/05/2005 | US20050096064 Access parameter adaptation and packet data resource management using detailed mobile status information |
| 05/05/2005 | US20050095242 Diagnostics and remedies for interstitial pneumonia |
| 05/05/2005 | US20050095238 Treating a disease associated with leukocyte infiltration of mucosal tissues, such as inflammatory bowel disease, asthma, graft vs host disease, pancreatitis, diabetes, or sinutitis with a humanized immunoglobulin or antigen-binding fragment thereof having binding specificity for alpha 4 beta 7 integrin |
| 05/04/2005 | EP1528058A1 Polymorphic crystalline forms of celecoxib |
| 05/04/2005 | EP1527343A2 Organic compounds |
| 05/04/2005 | EP1527196A2 Treatment for asthma or allergies |
| 05/04/2005 | EP1527178A2 Novel class ii cytokine receptors and uses thereof |
| 05/04/2005 | EP1527163A2 Preparation of type ii pneumocytes from stem cells |
| 05/04/2005 | EP1527100A2 Human monoclonal antibodies to interleukin-5 and methods and compositions comprising same |
| 05/04/2005 | EP1527074A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/04/2005 | EP1527070A1 Azole methylidene cyanide derivatives and their use as protein kinase modulators |
| 05/04/2005 | EP1527068A2 Novel arylimidazole derivatives, preparation and therapeutic uses thereof |
| 05/04/2005 | EP1527051A1 Pyrimidyl sulphone amide derivatives as chemokine receptor modulators |
| 05/04/2005 | EP1526895A2 Methods for treating carbonic anhydrase mediated disorders |
| 05/04/2005 | EP1526870A1 Novel combination of glucocorticoids and pde-4-inhibitors for treating respiratory diseases, allergic diseases, asthma and copd |
| 05/04/2005 | EP1526869A1 Compositions of a cyclooxygenase-2 selective inhibitor and a carbonic anhydrase inhibitor for the treatment of neoplasia |
| 05/04/2005 | EP1526860A2 Bioavailability/bioefficacy enhancing activity of cuminum cyminum and extracts and fractions thereof |
| 05/04/2005 | EP1526852A1 Bicyclo-pyrazoles active as kinase inhibitors, process for their preparation and pharmaceutical compositions comprising them |
| 05/04/2005 | EP1526847A2 Pharmaceutical dosage form comprising a sulfite compound |
| 05/04/2005 | EP1526846A2 Gelatin capsule exhibiting reduced cross-linking |
| 05/04/2005 | EP1526845A2 Pharmaceutical dosage form capable of maintaining stable dissolution profile upon storage |
| 05/04/2005 | EP1526844A2 Pellicle-resistant gelatin capsule |
| 05/04/2005 | EP1411881B1 5ht2c receptor modulators |
| 05/04/2005 | EP1395582B1 Novel piperidinecarboxamide derivatives, method for preparing same and pharmaceutical compositions containing same |
| 05/04/2005 | EP1377164A4 Erythropoietin ameliorates chemotherapy-induced toxicity in vivo |
| 05/04/2005 | EP1362048B1 Triazolo compounds as mmp inhibitors |
| 05/04/2005 | EP1341539B1 Anti-inflammatory agents |
| 05/04/2005 | EP1317448B1 Pyrazole compounds useful as protein kinase inhibitors |
| 05/04/2005 | EP1246790B1 Substituted 1 and 2 naphthol mannich bases |
| 05/04/2005 | EP1169029B1 Use of sibutramine or its derivative for the treatment of sleep disorders |
| 05/04/2005 | EP1147103B1 Phenantrhridine-n-oxides with pde-iv inhibiting activity |
| 05/04/2005 | EP1124810B1 2-amino-thiazole derivatives, process for their preparation, and their use as antitumor agents |
| 05/04/2005 | EP0781340B1 Vaccine against group A Streptococcal infection |
| 05/04/2005 | CN1612864A Novel alkansulfonamides as endothelin antagonists |
| 05/04/2005 | CN1612852A Lipoxin A4 analogs |
| 05/04/2005 | CN1612751A Combination treatments for allergic disease comprising administering an anti-IgE antibody and antiallergic compound |
| 05/04/2005 | CN1612745A Methods for slowing senescence and treating and preventing diseases associated with senescence |
| 05/04/2005 | CN1612739A Method for treating or preventing inflammatory diseases |
| 05/04/2005 | CN1612735A Uses for anti-malarial therapeutic agents |
| 05/04/2005 | CN1612734A Aqueous liquid preparations and light-stabilized aqueous liquid preparations |
| 05/04/2005 | CN1612733A Benzimidazoles useful as protein kinase inhibitors |
| 05/04/2005 | CN1612731A Composition inhibiting matrix-metallproteinases for the treatmentof neoplastic diseases |
| 05/04/2005 | CN1612729A 2-aryl-propionic acid and medicine composition containing same |
| 05/04/2005 | CN1612698A Modified methionine rich food products and process for their manufacture |
| 05/04/2005 | CN1611262A Method for preparing medicine with proteinase inhibiting function and its detecting method |
| 05/04/2005 | CN1611259A Cordyceps militaris tablet and its preparing method |
| 05/04/2005 | CN1611235A Medicinal composition for immunological disease and its preparing method |
| 05/04/2005 | CN1611215A Pharmaceutical use of dihydro myricetin |
| 05/04/2005 | CN1611213A Novel 13 uses of neoarsphenamine |
| 05/04/2005 | CN1199987C Basic monocyclic compounds having NK2 antagonist action, processes for their preparation and formulations containing them |
| 05/04/2005 | CN1199971C Quaternary ammonium compounds as tachykinin antagonists |
| 05/04/2005 | CN1199957C 'Sqiqu site' derivative and its preparing method as well as its activity of anti asthma |
| 05/03/2005 | US6887998 Process for 8-carboxamido-2,6-methano-3-benzazocines |
| 05/03/2005 | US6887903 N-(2-aryl-propionyl)-sulfonamides and pharmaceutical preparations containing them |
| 05/03/2005 | US6887865 N-heterocyclic derivatives as NOS inhibitors |
| 05/03/2005 | US6887845 Polypeptoid pulmonary surfactants |
| 05/03/2005 | US6887472 That do not cause anaphylaxis, antigenic fusion proteins of given amino acid sequence, of a CH3 domain of an immunoglobulin (IgE) molecule; allergy vaccines; vaccine test methods in dogs |
| 05/03/2005 | US6887459 Administering inhalant with particulate carrier or diluent for treatment of chronic obstructive pulmonary disease |
| 05/03/2005 | CA2347950C Pyrazolopyrimidinone cgmp pde5 inhibitors for the treatment of sexual dysfunction |
| 05/03/2005 | CA2309558C Substituted oximes as neurokinin antagonists |
| 05/03/2005 | CA2147623C Novel p-selectin ligand protein |
| 05/03/2005 | CA2133337C Compounds useful for treating allergic or inflammatory diseases |
| 05/03/2005 | CA2114114C Trisubstituted phenyl derivatives as selective phosphodiesterase iv inhibitors |
| 04/28/2005 | WO2005037839A1 Norcantharidin derivative compounds, method for the production thereof, compositions containing said compounds and the use thereof |
| 04/28/2005 | WO2005037814A1 Novel tricyclic spiroderivatives as modulators of chemokine receptor activity |
| 04/28/2005 | WO2005037299A1 Method for the production of a storage-resistant ivy leaf extract, and extract produced according to said method |
| 04/28/2005 | WO2005037298A1 Method for the production of ivy leaf extracts, and extract produced according to said method |
| 04/28/2005 | WO2005037224A2 Muscarinic acetylcholine receptor antagonists |
| 04/28/2005 | WO2004098634A3 Protein arginine n-methyltransferase 2 (prmt-2) |
| 04/28/2005 | WO2004075988A3 Methods of immunomodulation in animals |
| 04/28/2005 | WO2004014842A8 Acylated arylcycloalkylamines and their use as pharmaceuticals |
| 04/28/2005 | WO2003099201A3 Compositions and methods of use for a fibroblast growth factor |
| 04/28/2005 | WO2003072067A3 Compositions and methods for treating epithelial and retinal tissue diseases |
| 04/28/2005 | WO2003044170A3 Cyclic amp phosphodiesterase 4d7 isoforms and methods of use |